New drug trial offers hope for Tough-to-Treat eczema

NCT ID NCT07037901

Recruiting now Disease control Sponsor: Inmagene LLC Source: ClinicalTrials.gov ↗

Summary

This study is testing a new drug called IMG-007 to see if it can reduce the severity of eczema and is safe for adults with moderate-to-severe cases. It will compare different doses of the drug against a placebo (an inactive substance) in about 220 people over 52 weeks. The goal is to find the best dose to control the skin inflammation and intense itching associated with this condition.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Antelope Valley Clinical Trials
RECRUITING

Lancaster, California, 93534, United States
Apex Clinical Research Center
RECRUITING

Mayfield Heights, Ohio, 44124, United States
Arlington Dermatology
RECRUITING

Rolling Meadows, Illinois, 60008, United States
ClinOhio Research Services LLC.
RECRUITING

Columbus, Ohio, 43213, United States
Darst Dermatology
RECRUITING

Charlotte, North Carolina, 28277, United States
DermEdge Research
RECRUITING

Mississauga, Ontario, L4Y 4C5, Canada
Dermatology of Seattle & Bellevue
RECRUITING

Burien, Washington, 698168, United States
Dr. Chin-ho-Hong Medical Inc.
RECRUITING

Surrey, British Columbia, V3R 6A7, Canada
Forest Hills Dermatology Group
RECRUITING

Kew Gardens, New York, 11415, United States
Inmagene Site 1
RECRUITING

New York, New York, 10029, United States
Innovaderm Research Inc.
RECRUITING

Montreal, Quebec, H2X 2V1, Canada
North Bay Dermatology Centre
RECRUITING

North Bay, Ontario, P1B 3Z7, Canada
Oregon Dermatology and Research Center
RECRUITING

Portland, Oregon, 97210, United States
PacificDerm
RECRUITING

Vancouver, British Columbia, V6H 4B1, Canada
Palm Harbor Dermatology PA d/b/a TrueBlue Clinical Research
RECRUITING

Tampa, Florida, 33609, United States
Palmetto Clinical Trial Services, LLC
RECRUITING

Anderson, South Carolina, 29621, United States
Red River Research Partners, LLC
RECRUITING

Fargo, North Dakota, 58103, United States
Renstar Medical Research
RECRUITING

Ocala, Florida, 34470, United States
Skinsense Medical Research
RECRUITING

Saskatoon, Saskatchewan, S7K 2C1, Canada
Stryde Research-Epiphany Dermatology
RECRUITING

Southlake, Texas, 76092, United States
Sudbury Skin Clinique
RECRUITING

Greater Sudbury, Ontario, P3C 1X8, Canada
UCLA Division of Dermatology
RECRUITING

Los Angeles, California, 90095, United States
Vitality Clinical Trials LLC
RECRUITING

Woodbury, New York, 11797, United States

Conditions

Explore the condition pages connected to this study.

ATOPIC DERMATITIS ATOPIC DERMATITIS (ECZEMA) ECZEMA